Spyre Therapeutics Inc. Net Asset Quality Index
Spyre Therapeutics Inc. net asset quality index. Spyre Therapeutics Inc. (SYRE) has a Net Asset Quality Index of 93.9% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.17 Billion minus total liabilities of $71.86 Million yields net assets of $1.10 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Spyre Therapeutics Inc. (SYRE) shareholders funds for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Spyre Therapeutics Inc. (2013–2025)
Net asset quality index of Spyre Therapeutics Inc. from 2013 to 2025. This chart shows how Spyre Therapeutics Inc.'s Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of June 2026, the index stands at 93.9%, representing net assets of $1.10 Billion against total assets of $1.17 Billion USD. Check Spyre Therapeutics Inc. tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Spyre Therapeutics Inc. Net Asset Quality Index by Year (2013–2025)
Spyre Therapeutics Inc. net asset quality index by year from 2013 to 2025. The table below presents the year-by-year Net Asset Quality Index for Spyre Therapeutics Inc. from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Spyre Therapeutics Inc..
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 92.0% | $715.24 Million | $777.78 Million | $62.55 Million | ▲ +6.9 pp |
| 2024 | 85.1% | $517.80 Million | $608.48 Million | $90.68 Million | ▲ +31.3 pp |
| 2023 | 53.8% | $184.02 Million | $341.86 Million | $157.84 Million | ▼ -16.9 pp |
| 2022 | 70.7% | $50.30 Million | $71.14 Million | $20.84 Million | ▼ -5.7 pp |
| 2021 | 76.4% | $83.94 Million | $109.93 Million | $25.98 Million | ▼ -10.2 pp |
| 2020 | 86.5% | $139.83 Million | $161.62 Million | $21.79 Million | ▲ +14.3 pp |
| 2019 | 72.2% | $60.08 Million | $83.18 Million | $23.10 Million | ▼ -14.5 pp |
| 2018 | 86.7% | $67.43 Million | $77.74 Million | $10.31 Million | ▼ -3.0 pp |
| 2017 | 89.8% | $50.34 Million | $56.08 Million | $5.74 Million | ▼ -4.1 pp |
| 2016 | 93.9% | $62.97 Million | $67.06 Million | $4.10 Million | ▲ +0.5 pp |
| 2015 | 93.4% | $36.10 Million | $38.65 Million | $2.55 Million | ▲ +29.5 pp |
| 2014 | 63.9% | $1.87 Million | $2.93 Million | $1.06 Million | ▼ -5.4 pp |
| 2013 | 69.3% | $3.19 Million | $4.60 Million | $1.41 Million | — |